Tumor has been described as the wounds that do not heal. The two share some common features, such as loss of polarized tissue structure and chronic inflammation. We showed that disruption of tissue polarity induced macrophage infiltration. However, little is known of how disruption of epithelial cell polarity at early stage of breast cancer development induces macrophage infiltration. We have identified the RAR-related orphan nuclear receptor ? (ROR?) as a potent tumor suppressor by analyzing global gene expression profiles in polarized and non-polarized mammary epithelial cells. Our recent findings show that ROR? inhibits ROS generation and macrophage infiltration in the syngeneic mouse mammary tumor model. These results suggest that ROR? is a potent suppressor of macrophage infiltration in mammary epithelial cells. We found that knockdown of ROR? significantly induced ROS production in mammary epithelial cells. Reactive oxygen species (ROS) are the driver of cancer progression and critical regulator of the NF-?B pathway. Based on these novel findings, the central hypothesis of our proposal is that downregulation of ROR? in non-polarized breast cancer cells increased ROS generation in mitochondria, thereby inducing NF-?B and macrophage infiltration. We integrate high-throughput metabolic analysis, a novel 3D co-culture system, and global gene expression profiling to delineate mechanisms by which ROR? inhibits ROS production and macrophage infiltration. The long-term goal of this proposal is to define the impact of the ROR?/ROS axis in mediating mammary epithelial cell-macrophage crosstalk and in regulating breast cancer progression. We have proposed following specific aims to test the hypothesis:
Aim 1. To elucidate the molecular mechanisms by which ROR? reduces ROS levels and NF-?B activity in polarized mammary epithelial cells;
Aim 2. To determine how reduced ROR? expression in non-polarized breast cancer cells induces macrophage infiltration and M2 polarization;
Aim 3. Define the impact of ROR? in suppressing breast cancer formation and metastasis. The proposed study is high impact for its inherent scientific importance and its translational potential. This study will elucidate the molecular mechanism by which disruption of tissue polarity induces macrophage infiltration/differentiation. Determining roles of ROR? in reducing ROS generation and inhibiting NF-?B activation may identify a novel strategy to inhibit breast cancer development and progression.

Public Health Relevance

Characterizing the molecular link between disruption of mammary tissue polarity and macrophage infiltration and elucidating the mechanism by which ROR? repressing ROS generation and NF-?B activity will fill critical gaps in our knowledge about cancer-associated chronic inflammation and breast cancer progression. Determining whether inducing ROR? activity represses breast progression and metastasis will help identify potential druggable targets.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA215095-02
Application #
9444516
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Snyderwine, Elizabeth G
Project Start
2017-07-01
Project End
2022-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40526
Xiong, Gaofeng; Stewart, Rachel L; Chen, Jie et al. (2018) Collagen prolyl 4-hydroxylase 1 is essential for HIF-1? stabilization and TNBC chemoresistance. Nat Commun 9:4456
Qi, Yifei; Xu, Ren (2018) Roles of PLODs in Collagen Synthesis and Cancer Progression. Front Cell Dev Biol 6:66
Zhang, Hui; Fredericks, Tricia; Xiong, Gaofeng et al. (2018) Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance. Breast Cancer Res 20:116
Wang, Shike; Li, Zhenyu; Xu, Ren (2018) Human Cancer and Platelet Interaction, a Potential Therapeutic Target. Int J Mol Sci 19: